India's Sun Pharma to buy Organon in $11.75 billion all-cash deal
Under the definitive agreement, Sun Pharma will buy all the outstanding shares of Organon for $14.00 per share in cash, the companies said in a joint statement.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
